Chapter Outline
- ➢ Nontubercular osteoarticular infections
- ➢ Osteoarticular tubercular infections
Introduction
Pediatric osteoarticular infections remain a significant cause of morbidity worldwide. Although many concepts regarding pathogenesis, diagnosis and treatment of pediatric osteoarticular infections have remained constant over the years, understanding regarding various other aspects and epidemiology have continued to evolve.1 Clinicians caring for children need to be especially well versed in these newer concepts as they can be used to guide evaluation and treatment.
Nontubercular Osteoarticular Infections
Acute Osteomyelitis
The incidence of osteomyelitis in children is 0.2-1.6/1000 children/year.2 Wide variations are observed globally with incidence rates as low as 1/1000 in US and 1/5000 in UK for neonatal osteomyelitis.3 Acute hematogenous osteomyelitis is most common in childhood with a peak incidence in neonates.4–8 A small peak also occurs in early school age.9 There is a seasonal variation, with the hospital admission rate for osteomyelitis peaking in late summer and autumn.10 The incidence is greater in boys than girls (2.5:1) and the male to female sex ratio increases with age.2,10–13 In a combined group of childhood osteoarticular infections, the approximate proportion of osteomyelitis to septic arthritis is approximately 1.8:1.14 A few studies indicate racial differences with disease being more common in Aboriginal (indigenous people of Australia) and New Zealand Maori than European children.10
A few studies from UK (Glasgow, Scotland, England and Wales) and Australia reported reduced incidence of acute hematogenous osteomyelitis labeling it as a rare disease and demonstrated significant change in its characteristics over the past 3 decades (Table 1-1). They listed improvements in living standards, personal hygiene and general health, greater awareness, earlier diagnosis and the use of more sophisticated diagnostic tools as the reasons for decreased incidence of acute osteomyelitis.5,10 The patients in the investigated centers were now more likely to present with less florid subacute disease than a classical presentation with high grade fever and raised blood counts. Methicillin resistant Staphylococcus aureus (MRSA) induced bone and joint infections were more in numbers and Haemophilus influenzae as a causative organism has vanished in western centers following vaccination. Less long-term sequelae were reported with this form of subacute osteomyelitis.
|
These studies suggested that no antibiotic coverage was necessary for Haemophilus influenzae.
On the other hand, other developed countries (USA) in the North American continent are reporting overall increased incidence of musculoskeletal infections (osteomyelitis).14 In a study from Dallas (USA), the incidence of osteomyelitis increased from 11.7 cases per year to 70.7 cases per year indicating a 2.8 fold increase of the annualized per capita incidence. Moreover, the multifocal osteomyelitis variety is also on the rise. This trend is supposedly due to evolving organism potential to cause deep bone infection.14
The most commonly affected long bones are the tibia and femur but involvement of almost every bone in the body has been reported (Table 1-2).1,2,13 In a study of 163 infants and children with osteomyelitis, the femur, tibia, and humerus accounted for 68% of infections.6 Most cases were limited to a single site, with less than 10% involving two or more locations (multifocal). The metaphysis of long bones is the most usual site for acute hematogenous osteomyelitis.13,16
Septic Arthritis
Although septic arthritis can occur at any age and in any joint, it occurs predominantly in children, in the hip and knee (Table 1-2). Half of all cases of septic arthritis occur in those less than 20 years old.13,16 Rates of septic arthritis are estimated to be between 5.5 and 12 cases per 100,000 children with a peak incidence in the early years of the first decade.13 Incidence of septic arthritis is as less as 1/100,000 in US children-based studies.14 On the other side of spectrum, high incidences of 5-20/100,000 are found in African studies.17,18 Again boys are affected twice as girls as they are more likely to involve in activities leading to repetitive minor joint trauma.19
|
The most common sites of septic arthritis are hip and knee. In certain anatomical sites, the bony metaphysis is intracapsular and any bone infection may lead to septic arthritis (concomitant septic arthritis and osteomyelitis), e.g. upper end of femur, proximal humerus, proximal radius, lower tibia and distal fibula (Table 1-2). The bony metaphyses of children younger than 18 months are vascularized by the transphyseal vessels.
Because these vessels enter the epiphysis and ultimately the joint space, young children are believed to have a higher risk of joint space infection complicating osteomyelitis.1,20
Organisms
The type of infecting organism for osteoarticular infections depends on the age of the child and any associated medical problem (Tables 1-3 and 1-4).
Staphylococcus aureus is the most common cause of osteomyelitis in all age groups, accounting for 70-90% of infections. It is perhaps because of its capacity to express bacterial adhesions that promote attachment to extracellular bone matrix. This organism also is able to evade host defenses, attack host cells, and colonize bone persistently. However, 20-70% of osteoarticular infections cases may be culture negative despite collection of blood, joint fluid, and bone for culture.1,7,13
Since the initiation of the use of penicillin in the early 1940s, methicillin resistance has become increasingly common among strains of Staphylococcus aureus (methicillin resistant Staphylococcus aureus, MRSA). However, methicillin sensitive Staphylococcus aureus (MSSA) is still the most common pathogenic organism. More recently, the incidence of community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) has increased globally (Table 1-5).
|
Infections caused by CA-MRSA have a more serious presentation than MSSA. A US study reported that osteomyelitis comprise 84% of the musculoskeletal MRSA infections, while septic arthritis and pyomyositis occurred in 10% and 6% respectively.22 More recently highly virulent strains USA 300 have been identified exhibiting as disseminated infections in pediatric age group.26
In neonates, besides Staphylococcus aureus, infections with gram-negative organisms, Group B Streptococcus and Candida are common (Table 1-3). Streptococcus pyogenes causes approximately 10% of cases of acute hematogenous osteomyelitis with a peak incidence of disease in preschool-age and early school-age children. Children with Streptococcus pyogenes osteomyelitis often have a recent history of varicella infection and present with higher fever and white blood cell (WBC) counts compared with children infected with Staphylococcus aureus.
|
Children with osteomyelitis caused by Streptococcus pneumoniae are younger than children infected with Staphylococcus aureus and Streptococcus pyogenes. They are more likely to have joint involvement.
The incidence of Haemophilus influenzae as a pathogen in children under four years is decreasing with the use of vaccination against Haemophilus influenzae type b. Incidence of septic arthritis due to Haemophilus influenzae type b (Hib) prior to introduction of vaccine was estimated to be 6/100,000 per year.27 It was the most common cause of septic arthritis in age group 6 months-5 years. International experience has shown that vaccination is effective and brings down the rate of septic arthritis attributable to Haemophilus influenzae drastically. In Finland, the Hib vaccination was introduced in 1986. Prior to introduction of vaccine, 36% of septic arthritis cases (1982-1988) were due to Hib. Following vaccination initiation, no cases due to Hib were reported after 1989.27 The conjugate vaccine against Haemophilus influenzae type b (Hib) was introduced in US in 1988 and thereafter incidence of invasive disease due to Hib (includes meningitis, pneumonia, septicemia, peritonitis, epiglottitis, osteoarticular infections, etc.) has decreased by more than 95%-1.6/100,000 children under 4 years of age by 1995.28
Newer fastidious organisms such as Kingella kingae are now being detected in increasing frequency. In fact, in a recent report it was found that Kingella kingae has become the most common cause of osteoarticular infections (septic arthritis > osteomyelitis) in French children younger than 3 years of age.29 Other European centers have confirmed these findings.23,30 The apparently increasing prevalence of Kingella seems more because of better isolation techniques rather than an overall change in epidemiology of bone and joint infections.31
Patients with sickle cell disease have been documented to be particularly susceptible to osteoarticular infections.1,13 Osteomyelitis and septic arthritis are two of the infectious complications of sickle cell disease. Organisms causing bone infection in children with sickle cell disease include Salmonella and Staphylococcus aureus and less commonly Escherichia coli, Shigella, and Streptococcus pneumoniae. The peculiar association of sickle cell anemia with Salmonella species osteomyelitis was documented by Carrington et al in 1925 and subsequently confirmed by many authors.32–34 Around 75% of osteoarticular infections in children without sickle cell disease have been attributed to Staphylococcus species. This is in contrast to osteomyelitis in children with sickle cell disease in which Salmonella species has been implicated in 60–80% of cases.
Anaerobes are a rare cause of pyogenic osteomyelitis in healthy children. Predominant organisms are Bacteroides, Fusobacterium, Clostridium, and Peptostreptococcus. Anaerobic osteomyelitis can occur as the result of a bite, chronic sinusitis, mastoiditis, or dental infection. Unusual causes of osteomyelitis include infection with Mycobacterium, Bartonella, Coxiella burnetii, or fungi (Table 1-4). Fungal osteomyelitis is occasionally seen in immunocompromised individuals and is usually 5caused by Coccidioides immitis, Blastomyces dermatitidis, Histoplasma capsulatum, Cryptococcus neoformans, Aspergillus, etc.1
Puncture wounds to the foot may result in osteomyelitis caused by mixed flora, including Pseudomonas, Staphylococcus aureus, enteric gram-negative bacteria, and anaerobes. A number of series describe osteomyelitis of the metatarsals occurring as a result of toothpick puncture injuries. The organisms isolated included skin and environmental organisms; others have reported infection with mouth organisms as a result of toothpick injuries.35
The infection rates in open pediatric fractures are somewhat lower than the adults. Patzakis and Wilkins evaluated seventy-seven infections in 1104 open fracture wounds.36 They reported just one infection (1.8%) in 55 open fractures in children compared to average infection rate of 72% in 1049 open adult fractures. Skaggs et al (1989-2000) conducted a retrospective, multicenter study of open fractures in children.37 The analysis included 554 open fractures in 536 consecutive patients, who were eighteen years of age or younger. The overall infection rate was 3%. Specifically, the infection rates when the fractures were dealt within 6 hours were 2% for Gustilo Anderson type I, 3% for type II and 10% for type III fractures. Typically the infecting organism was Staphylococcus aureus and aerobic or facultative gram-negative rods in fractures with less soft tissues injury and mixed flora was found in type IIIB and C fractures.37
Risk Factors
Preceding trauma is less common in septic arthritis than in osteomyelitis. Several risk factors for osteoarticular infections have being identified in children: young age, male gender, respiratory distress syndrome, umbilical artery catheterization, predisposition to infection, e.g. presence of sickle cell hemoglobinopathy, immunodeficiency, diabetes, prematurity, low birth weight or underdevelopment.21 However, even in developing as well as developed countries, socioeconomic deprivation was not considered an association.4 Most children who receive appropriate therapy for osteomyelitis have no long term sequelae. Complication rates following osteomyelitis are 11-29%.9 The reported incidence of sequelae in neonates with osteomyelitis are higher and ranges from 6-50%.1,13 Complications are reported in approximately 10-25% of all pyogenic arthritis. Common factors indicating poor outcome and sequelae are onset of disease in infancy, associated septic arthritis and osteomyelitis and infection caused by Staphylococcus aureus or gram-negative bacteria. Other poor prognosticating factors identified from African countries are delay in initiation of appropriate and timely treatment, initial misdiagnosis, involvement of hip, shoulder or polyarticular infections and circumferential periosteal stripping observed during surgery.17,18
Immunocompromised hosts may have a higher incidence, particularly those suffering from inflammatory arthritis of any type. Two reports have identified an increased incidence of septic arthritis in children who have hemophilia and are HIV positive.38,39
Pyomyositis
Pyomyositis is a bacterial infection of skeletal muscle with a predilection for large muscle groups, and it often results in localized abscess formation. Although relatively uncommon in more temperate areas, such as North America, pyomyositis accounts for up to 4% of surgical admissions in some tropical areas.13 This geographic distribution has led to the alternative name of pyomyositis tropicans. Within North America, the highest incidence of pyomyositis is in the southernmost regions. In children, the peak incidence occurs between 5 and 9 years of age.13,40
Pyomyositis most commonly affects the quadriceps, gluteal, and iliopsoas muscles. Other affected areas include the paraspinous, shoulder girdle, extremities (e.g. gastrocnemius), chest wall, and abdominal wall. Patients with psoas muscle involvement may present with limp, hip pain, or back pain. Multiple sites are involved in 11-43% of patients.41–46
Indian Scenario
Scanty data is available for epidemiology of osteoarticular infections in children in India. In India, the reported incidence of septic arthritis is 1/1500.47 In a combined adult and children study on osteomyelitis from northern India, Staphylococcus aureus (43%) was the most common causative organism in children. Methicillin resistance was observed in 30% Staphylococcus aureus isolates. Multidrug resistance (56%) and quinolone resistance (75%) was also common among Staphylococcus aureus strains.48
However, in a series of nosocomial neonatal osteomyelitis, joint fluid cultures were positive for gram-negative (33%) and fungus (7%) as well, besides gram-positive organisms (20%). The remaining 40% were culture negative.49 Prematurity and low birth weight were identified as risk factors in this Indian study. The authors reported a better outcome with early arthrotomy.
6A multicenter study on septic arthritis from northern Indian revealed that majority of subjects (42%) were below age of 1 month. Hip (42%) and knee joints (39%) were involved in maximum numbers. Associated osteomyelitis and joint destruction with instability was present in 35% of the cases each at presentation. A predominant male ratio and gram-positive (Staphylococcus aureus) causative organism was seen.50
The India Invasive Bacterial Infections Survillence (IBIS) project provided multicenter, hospital-based epidemiological data on the characteristics of Haemophilus influenzae invasive infections in India (1994-2005).51 The incidence of Haemophilus influenzae meningitis in India is 39-66/100,000 annually in 0-4 year olds. The study determined that meningitis (34%) was the predominant manifestations of all invasive diseases caused by Haemophilus influenzae and serotype b caused most of the invasive disease including bone and joint infections. Up to 5% of cases were Haemophilus influenzae bone and joint infections. Septic arthritis was more common than osteomyelitis with this organism. The disease could be prevented to a large extent by incorporation of Haemophilus influenzae (Hib) vaccine in the expanded immunization programme in India.52 Hib vaccination in India was introduced in India in 1997 and has been recommended by Indian Academy of Pediatrics since 1999.53 A study from South India documented the useful community effect of Hib vaccination.54 Prior to vaccination the annual mean number of Hib meningitis in the region was 10.7 (1994-1996), in less than 5 years age group. It fell to 3.8 (2001-2005) cases after vaccination.54 Corresponding decrease is expected in other invasive disease like septic arthritis caused by Haemophilus influenzae with effective vaccination although there is no data available pertaining to the reduction of osteoarticular infection by this organism.
Osteoarticular Tubercular Infections
Incidence
A number of studies have been published on the epidemiological aspects of tuberculosis in the past decade. Most of these studies focus on national trends and adult populations, but not much is known about the tuberculosis burden in children.
According to WHO estimations (2010), the incidence of new tuberculosis cases in 2009, was 9.4 million with 14 million prevalent cases, most of which occurred in the South-East Asia region.55 Mycobacterium tuberculosis is estimated to infect almost 30% of world's population. 50% of the reported cases occurred in five countries (Bangladesh, China, India, Indonesia and Nigeria). Yet by global and regional effort in case detection and implementation of DOTS in developing countries, the prevalence of tuberculosis decreased globally between 1990 and 2003 from 309-245/100,000 population.56 Tuberculosis is entering into new era with multidrug resistance (MDR) strains coming into vogue. According to WHO, 33% of all new tuberculosis cases have MDR tuberculosis.55 Extreme drug resistance (XDR) forms are also reported from 58 countries. An 11-13% of incident cases are HIV positive. The reported proportion of extrapulmonary tuberculosis—EPTB (including bone and joint tuberculosis) among all tuberculosis cases in developed countries ranges from 12-28.5%.57 Bone and joint tuberculosis constitutes approximately 10% of all EPTB cases.
The incidence and prevalence of pediatric tuberculosis worldwide varies significantly according to the burden of the disease in different countries. World Health Organization (WHO) has quoted that children with tuberculosis represent up to 20% of all tuberculosis cases. The majority of these cases occur in low income countries where the prevalence of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is high. In 2000, out of 8.3 million cases of tuberculosis worldwide, 11% occurred in children less than 15 years. This represents only children having active, symptomatic tuberculosis. Most children will, however, have asymptomatic latent infection which is difficult to detect as children are generally smear negative on sputum examination. This means that children can account for up to 25-40% of tubercular cases with incidence rates for pediatric tuberculosis ranging from 60-600/100000 children per year.58 Rough estimates of tuberculosis from 22 countries with highest load of tuberculosis, give it's occurrence in children in range from 2.7–25.3%. They can account for 10% of all hospital admissions in developing countries. An active surveillance study from South Africa reported incidences as high as 49% of new case notifications in children aged 0-14 years.58 In Europe and North America traditionally considered low burden countries, children account for 4-7% 7of cases and pediatric incidence rates vary from 1-15/100,000/year.58
The overall occurrence of extrapulmonary tuberculosis in children is unknown; approximate estimations range between 10-30%. Tuberculosis of bones and joints occur in 5-6% in cases of pediatric extrapulmonary tuberculosis. Symptomatic disease usually occurs 1-3 years after infection although tubercular dactylitis can be an early manifestation (1 month). The most common is vertebral involvement (thoracic > lumbar > cervical). Multiple vertebral involvement is common (80%). Other common sites are hip (20%), knee (10%), ankle and foot (5%), hand and wrist (3%), elbow (2%), shoulder (1%), bursal sheaths and other bones (8%).59,60
In areas where the prevalence of HIV infection is high, the children (both infected and affected) are at high-risk of tubercular infection due to close proximity with young adults who are most likely to be HIV-infected and in whom tuberculosis is the most common opportunistic infection. Further, due to the high prevalence of other opportunistic infections among HIV infected children and the lack of a gold standard, diagnosis of tuberculosis is often a challenge in this population. The deadly synergy of human immunodeficiency virus (HIV) and tuberculosis and the emergence of multidrug-resistant Mycobacterium tuberculosis have further complicated the issue.
Other Mycobacterium such as human Mycobacterium bovis also infects children. In developed countries, reported incidence of human Mycobacterium bovis infections is 1-2% of human tuberculosis cases. It is zoonosis with transmission mainly through unpasteurized contaminated dairy products. The risk factors include patients from endemic regions, hispanic patients, patient < 15 years, HIV infected, and extrapulmonary tuberculosis. A study in US indicated that human Mycobacterium bovis retains its susceptibility to pyrazinamide in significant number of patients.61 Isolated reports of other opportunistic mycobacterial infections are also available in literature.62,63
Coinfection with HIV
The effect of the HIV epidemic on the burden of tuberculosis in children is less well studied than for adults. However, children are supposed to be at high-risk of exposure as well as manifesting disease. The rate of HIV coinfection with tuberculosis varies from less than 5% in industrialized and developed areas to over 50% in high burden African countries.58 In developing countries, tuberculosis is now recognized as one of the most common opportunistic infection in patients seropositive for HIV. In African continent, positive HIV serology is associated in 17-55% of tuberculosis patients. Further, extrapulmonary tuberculosis and mediastinal lymphadenopathy is significantly more common in HIV positive (60-65%) compared to HIV negative (25%) patients. People infected with tubercle bacilli and HIV are 30 times more likely to develop active tuberculosis in a given year than those infected with tuberculosis alone.64
Indian Scenario
India accounts for one-third of the global tuberculosis burden with 1.8 million developing disease each year. According to WHO reports, India, China, Pakistan, the Philippines, Thailand, Indonesia, Bangladesh, and the Democratic Republic of the Congo account for nearly 75% of all cases of pediatric tuberculosis. The average prevalence of all forms of tuberculosis in India is estimated to be 5.05 /1000, prevalence of smear positive cases 2.27/1000 and annual incidence of smear positive cases at 84/100,000 annually. The annual risk of infection in various areas varies from 0.61-3.8%. Not much data is available on prevalence and incidence of tuberculosis and mortality rates in children in the Indian community. In most tuberculosis surveys carried out in India, children below 5 or even 9 years were excluded. Screening the children in mass surveys is difficult as children are generally smear negative.
Considerable differences exist in the infection rates among children from area to area within the country due to differences in socioeconomic conditions in the Indian population. Prevalence of tuberculosis infection in children in India in the age group of 0-14 years is reported to be between 2–10%. The incidence of infection (fresh infection in a year among those previously uninfected, also termed Annual Risk of Infection (ARI), has been observed to be 3% among the urban slum children in India. The risk of developing disease appeared to be the highest among the newly infected (20.0 per thousand per year) and the least among the initially noninfected children (1.2 per thousand per year). The risk among the initially infected children is approximately 8.8 per thousand per year. The magnitude of drug resistance among previously treated cases varies widely. With 8treatment failures and relapses, rifampicin resistance is 37.3% (Gujarat, 1986), isoniazid (55.8%) and MDR (30%). However drug resistance among fresh cases is relatively lower. The rates could be as low as 5-10% resistance to isoniazid and nil for rifampicin in Indian children.64 In India (2006) 1.2-6.6% of MDR cases were XDR.65
HIV seroprevalence (2006-2007) among Indian tubercular patients varies widely from 1% in Kochi (Bihar) to 13.8% in Guntur (Andhra Pradesh). The seroprevalence was more in males (8.4%), smear negative (8%), extrapulmonary (7.4%) patients. The prevalence was higher (>5%) in Andhra Pradesh, Karnataka, Maharashtra, and Tamil Nadu.66 This has prompted Ministry of Health and Family Welfare (India) to adopt a policy of routinely offering voluntary HIV counseling and testing to all tuberculosis patients in these four states. Various other studies in India report 14-67.5% coinfection with HIV in tuberculosis infected children.56
References
- Gutierrez K. Bone and joint infections in children. Pediatr Clin N Am. 2005;52:779–94.
- Gavilán MG, López JB, Artola BS. Peculiarities of osteo-articular infections in children. Baillieres Best Pract Res Clin Rheumatol. 1999;13:77–94.
- Dhir R. Bone and joints infections in neonates. J Neonatology. 2006;20:36–44.
- Blyth MJ, Kincaid R, Craigen MA, et al. The changing epidemiology of acute and subacute hematogenous osteomyelitis in children. J Bone Joint Surg Br. 2001;83:99–102.
- Craigen MA, Watters J, Hackett JS. The changing epidemiology of osteomyelitis in children. J Bone Joint Surg Br. 1992;74:541–5.
- Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children: a review of 163 cases. Am J Dis Child. 1975;129:1273–8.
- Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis. J Pediatr Orthop. 2006;26:703–8.
- La Mont RL, Anderson PA, Dajani AS, et al. Acute hematogenous osteomyelitis in children. J Pediatr Orthop. 1987;7:579–83.
- Pääkkönen M, Peltola H. Antibiotic treatment for acute hematogenous osteomyelitis of childhood: Moving towards shorter courses and oral administration. Int J Antimicrob Agents. 2011;38:273–80.
- Gillespie WJ. The epidemiology of acute hematogenous osteomyelitis of childhood. Int J Epidemiol. 1985;14:600–6.
- Nelson JD. Acute osteomyelitis in children. Infect Dis Clin North Am. 1990;4:513–22.
- Vaughan PA, Newman NM, Rosman MA. Acute hematogenous osteomyelitis in children. J Pediatr Orthop. 1987;7:652–5.
- Frank G, Mahoney HM, Eppes SC. Musculoskeletal infections in children. Pediatr Clin N Am. 2005; 52:1083–106.
- Gafur OA, Copley LA, Hollmig ST, et al. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop. 2008;28:777–85.
- Molyneux E, French G. Salmonella joint infection in Malawian children. J Infect. 1982;4:131–8.
- Lazzarini L, Mader J, Calhoun J. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86:2305–18.
- Lavy CB, Peek AC, Manjolo G. The incidence of septic arthritis in Malawian children. Int Orthop. 2005;29:195–6.
- Nunn TR, Cheung WY, Rollinson PD. A prospective study of pyogenic sepsis of the hip in childhood. J Bone Joint Surg Br. 2007;89:100–6.
- Shetty AK, Gedalia A. Septic arthritis in children. Rheum Dis Clin North Am. 1998;24:287–304.
- Perlman MH, Patzakis MJ, Kumar PJ, Holtom P. The incidence of joint involvement with adjacent osteomyelitis in pediatric patients. J Pediatr Orthop. 2000;20:40–3.
- Kang SN, Sanghera T, Mangwani J, et al. The management of septic arthritis in children: systematic review of the English language literature. J Bone Joint Surg Br. 2009;91:1127–33.
- Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23:701–6.
- Harik NS, Smeltzer MS. Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther. 2010;8:175–81.
- Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
- Newland JG, Kearns GL. Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics. Paediatr Drugs. 2008;10:367–78.
- Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA. 2009;106:5883–8.
- Peltola H, Kallio MJ, Unkila-Kallio L. Reduced incidence of septic arthritis in children by Haemophilus influenzae type-b vaccination. Implications for treatment. J Bone Joint Surg Br. 1998;80:471–3.
- Bisgard KM, Kao A, Leake J, et al. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229–37.
- Chometon S, Benito Y, Chaker M, et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J. 2007;263:77–81.
- Ceroni D, Cherkaoui A, Ferey S, et al. Kingella kingae osteoarticular infections in young children: clinical features and contribution of a new specific real-time PCR assay to the diagnosis. J Pediatr Orthop. 2010;30:301–4.
- Chambers JB, Forsythe DA, Bertrand SL, et al. Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediatr Orthop. 2000;20:682–5.
- Carrington GL, Davison WC. Multiple osteomyelitis due to Bacillus papatyphosus B demonstration of Bacillus in fresh blood preparation. Johns Hopkins Med J. 1925;36:428–30.
- Landesman SH, Rao SP, Akonkhai VI. Infections in children with sickle cell anemia. Special reference to pneumococcal and Salmonella infections. Am J Pediatr Hematol Oncol. 1982;4:407–18.
- Imoisili MA, Bonwit AM, Bulas DI. Toothpick punctures injuries of the foot in children. Pediatr Infect Dis J. 2004;23: 80–2.
- Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36–40.
- Skaggs DL, Friend L, Alman B, et al. The effect of surgical delay on acute infection following 554 open fractures in children. J Bone Joint Surg Am. 2005;87:8–12.
- Gregg-Smith SJ, Pattison RM, Dodd CA, et al. Septic arthritis in haemophilia. J Bone Joint Surg Br. 1993;75:368–70.
- Merchan ECR, Magallon M, Manso F, et al. Septic arthritis in HIV positive haemophiliacs. Int Orthop. 1992;16:302–6.
- Ameh EA. Pyomyositis in children: analysis of 31 cases. Ann Trop Paediatr. 1999;19:263–5.
- Chiedozi LC. Pyomyositis: review of 205 cases in 112 patients. Am J Surg. 1979;137:255–9.
- Chacha PB. Muscle abscesses in children. Clin Orthop Relat Res. 1970;70:174–80.
- Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J. 2000;19:1009–13.
- Spiegel DA, Meyer JS, Dormans JP, et al. Pyomyositis in children and adolescents: report of 12 cases and review of the literature. J Pediatr Orthop. 1999;19:143–50.
- Bickels J, Ben-Sira L, Kessler A, et al. Primary pyomyositis. J Bone Joint Surg Am. 2002;84:2277–86.
- Patel SR, Olenginski TP, Perruquet JL, et al. Pyomyositis: clinical features and predisposing conditions. J Rheumatol. 1997;24:1734–8.
- Narang A. Mukhopadhya K, Kumar P, et al. Bone and joint infections in neonates. Indian J Pediatr. 1998;65:461–4.
- Kaur J, Gulati VL, Aggarwal A, et al. Bacteriological profile of osteomyelitis with special reference to Staphylococcus aureus. Indian Journal for the Practising Doctor. 2008;4. Available at: http://www.indmedica.com/journals.php?journalid=3&issueid=123&articleid=1627&action=article. Assessed Jan 5, 2012.
- Deshpande SS, Taral N, Modi N, et al. Changing epidemiology of neonatal septic arthritis. J Orthop Surg (Hong Kong). 2004;12:10–3.
- Jain S, Tittal P, Rohilla N, et al. Acute septic arthritis revisited: a prospective study in 93 patients correlating C-reactive protein levels with duration of intravenous antibiotic therapy, clinical and radiological outcomes. Eur J Orthop Surg. 2009;19:447–55.
- Steinhoff MC. Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. IBIS (Invasive Bacterial Infections Surveillance) Group. Pediatr Infect Dis J. 1998;17:S172–5.
- Miller MA. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. Pediatr Infect Dis J. 1998;17:S152–9.
- Invasive Bacterial Infections Surveillance (IBIS) Group of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. Clin Infect Dis. 2002;34:949–57.
- Verghese VP, Friberg IK, Cherian T, et al. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J. 2009;28:738–40.
- World Health Organization. Global TB Control Report. 2010; Available at: http://www.who.int/tb/country/en/. Assessed Jan 5, 2012.
- Powell DA, Hunt WG. Tuberculosis in children: an update. Adv Pediatr. 2006;53:279–322.
- Peltola H. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. Bull World Health Organ. 1999;77:878–87.
- Newton SM, Brent AJ, Anderson S, et al. Pediatric tuberculosis. Lancet Infect Dis. 2008;8:498–510.
- Tuli SM. Tuberculosis of the Skeletal System. Jaypee; New Delhi: 2004.
- Watts HG, Lifeso RM. Tuberculosis of bones and joints. J Bone Joint Surg Am. 1996;78:288–98.
- Hlavsa MC, Moonan PK, Cowan LS, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin Infect Dis. 2008;47:168–75.
- Ozkaynak MF, Lenarsky C, Kohn D, et al. Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children. Am J Pediatr Hematol Oncol. 1990;12:220–4.
- Krieger I, Hahne OH, Whitten CF. Atypical mycobacteria as a probable cause of chronic bone disease: A report of two cases. J Pediatr. 1964;65:340–9.
- Chakraborty AK. Epidemiology of tuberculosis: current status in India. Indian J Med Res. 2004;120:248–76.
- Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–43.
- Raizada N, Chauhan LS, Khera A, et al. HIV seroprevalence among tuberculosis patients in India, 2006-2007. PLoS One. 2008;3:e2970.